ArticlePloS one2014

Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.

Seth A Brodie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.